Fuse Science Ships Over $500,000 in Orders for Quarter-End

New Post Public Reply Private Reply Replies (1) Message Board
Dago
Fuse Science Ships Over $500,000 in Orders for Quarter-End December 31st, 2013 and Takes Critical Steps to Secure Required Capital to Continue Execution of Business Model

MIAMI LAKES, FL--(Marketwired - Jan 6, 2014) - Fuse Science, Inc. (OTCQB: DROP) (www.fusescience.com), a consumer products and delivery technology company that is developing new, patent-pending technologies working to redefine how consumers receive energy, medicines, vitamins and minerals announced that it recently took further steps towards securing the additional capital to continue the ongoing execution of its business plan.
On Friday, January 3, 2014, the Company filed a Form 8-K in which Fuse announced that it had entered into a securities purchase agreement with two investors, pursuant to which Fuse agreed to issue and sell senior secured convertible notes in the aggregate original principal amount of $1,000,000, together with warrants to purchase common stock. Friday's filing can be viewed within the SEC filings section of the Fuse Science corporate web site at www.fusescience.com or at www.sec.gov.
In November 2013, the Company announced strategic investments from Muscle Pharm Inc., Phil Frost and others focused on the ongoing development of Fuse's proprietary technology and consumer products. Last Friday's investment is a further step in this effort. All strategic partners in the November 2013 round rolled their funding into the current round, moving the note terms from sixty days to a five-year maturity which allows Fuse to execute against its objectives.
This current action is the next step in a series of financial steps the Company is taking to provide for continued growth. Friday's investment of an additional $1MM in working capital consists of $550,000 funded on January 3, 2014. The $450,000 balance is expected to be funded in four (4) monthly installments of $100,000 and a final installment of $50,000.
During this time the Company will continue its efforts to advance the commercialization of its PowerFuse(R), ElectroFuse(R) and EnerJel(R) brands, leveraging its world class athletes while taking required administrative steps to ensure the next phase of business growth and funding. In November and December 2013, the Company completed production shoots and commercials with World Series MVP David Ortiz and Wimbledon Champ Andy Murray, which are center stage in the Company's advertising program. Fuse anticipates the scheduling of these productions during the first calendar quarter of 2014.
In addition, the Company reports that it shipped over $500,000 in product orders for its first quarter of fiscal year 2014, which ended December 31, 2013, which surpasses the entire previous 12 months -- illustrating optimism for continued sales growth under heavy working capital resource constraints.
Additional funding is still required to support the strategy and development of the Fuse business plan, both of which will require the authorization of additional shares to be issued. Upon shareholder approval, the Company will also execute a reverse stock split, to facilitate better structure around the market capitalization and stock price.
To become "Powered By Fuse(R)", visit your local Walgreens or Duane Reade store or go to www.poweredbyfuse.com.
About Fuse Science, Inc.
Fuse Science, Inc. (OTCQB: DROP), is an innovative consumer products and delivery technology company based in Miami Lakes, Florida. Fuse Science holds the rights to new, patent-pending technologies poised to redefine how consumers receive energy, medicines, vitamins and minerals. The Company maintains the rights to sublingual and transdermal delivery systems for bioactive agents that can now, for the first time, effectively encapsulate and charge many varying molecules in order to produce complete product formulations which can bypass the gastrointestinal tract and enter the blood stream directly - all in a concentrated "DROP" form that is simply applied under the tongue. The Fuse Science technology is designed to accelerate conveyance of medicines or nutrients relative to traditional pills and liquids and can enhance how consumers receive these products. Information about Fuse Science is available online at www.fusescience.com and www.poweredbyfuse.com or by calling 305-503-FUSE (3873).
For Fuse Science news as it happens, follow @FuseScience (https://twitter.com/fuse_science) on Twitter and Like Us on Facebook at https://www.facebook.com/FuseScience!
Get all Fuse Science corporate updates sent directly to you; sign up for Fuse News Alerts here: http://ir.stockpr.com/fusescience/email-alerts.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Quanta Services Reports Record Q3 2026 Earnings

Updated Category News Views 0

Quanta Services Smashes Q3 2026 Expectations If you're a stakeholder in Quanta Services, you'd probably be dancing in the aisles right now. This company just posted off-the-charts numbers for the third quarter of 2026. We're talking revenues of $12 billion—a staggering leap from $7.63 billion the same quarter last year. Explosive Earnings and Strong Backlog The star of...

Continue Reading
Faith on Trial: La Luz del Mundo Faces Court Ruling

Updated Category News Views 63

A Legal Battle Over Religious Freedom When folks start talking about religion intertwining with law, things get real tricky, real quick. The La Luz del Mundo church is knee-deep in such a legal tussle. On October 28, 2026, the United States District Court for the Southern District of New York gave a nod to the prosecution, denying the church's pretrial motions. What we've...

Continue Reading
2026 Data Integration Stars: User Sentiments Revealed

Updated Category News Views 65

Users Crown Data Integration Champions Right out of the gate, let's make one thing clear: when you're picking a data integration solution, you're essentially hitching your wagon to a vendor. This partnership, like any, can make or break your operations, and no one knows this better than the folks who've been through the trenches. Enter Infotech's 2026 Emotional Footprint...

Continue Reading
Banco Macro S.A. Plans $160B Share Buyback Initiative

Updated Category News Views 24

Tapping into Share Buybacks in a Tumultuous Market Out of nowhere, Banco Macro S.A. has decided to whip up a share buyback program, a lifeline for their current market value. Let me tell you, the market's more volatile than a caffeinated squirrel these days, hitting the financial scenery harder than a hammer on a glass table. So, Banco Macro's taken a deep breath and...

Continue Reading
Smartpress: Adobe & Canva Shape Print Design World

Updated Category News Views 115

Adobe's Stranglehold on Professional Design Over at Smartpress, they've pulled the curtain back on just how heavily Adobe Creative Suite weighs in on the print design sector. The company's recent analysis shines a light on the staggering 66% dominance of Adobe's InDesign and Illustrator in file submissions. That's a hefty portion influencing both the quality and financial...

Continue Reading
Atlantic Blvd Apartments: A Game-Changer for Housing

Updated Category News Views 31

A Bold Move for Attainable Housing Amidst the hustle and bustle of Sterling, Virginia, a new player has hit the scene: Atlantic Blvd Apartments. A property designed solely for attainable housing, this development is a showcase of what can be accomplished when local government and private developers team up with a shared vision. It feels like a breath of fresh air in a...

Continue Reading
Data Breach at Lumara Bio: Privacy Lawsuits Loom

Updated Category News Views 206

Another Day, Another Data Breach It seems like you can’t throw a stone without hitting a data breach these days—and this time, it’s Lumara Bio USA’s turn under the spotlight. The Princeton-based oncology therapeutics outfit, part of Germany’s ITM Isotope Technologies, spilled some beans it never meant to. We're talking some pretty sensitive stuff here, folks....

Continue Reading
Clip Expands Horizons with Pulpos Acquisition, New Board Member

Updated Category News Views 128

Clip's Strategic Move with Pulpos Clip just laid down a serious marker in the digital payment world by snagging Pulpos, a firm that’s got its claws deep into AI-driven business management software. This move isn't just some fancy headline. It's a real, grounded step in expanding Clip's ecosystem to bolster the backbone of Mexico's economy: small and medium-sized...

Continue Reading
Infection Control Market Set for Explosive Growth by 2031

Updated Category News Views 101

Untangling the Surge in Infection Control Demand Lately, it's like every healthcare joint worldwide is scrambling for better infection control. We're talking about a market poised to jump from a whopping USD 58.5 billion in 2026 to USD 80.2 billion by 2031—a tidy 37% uptick. That change, brewing at a 6.5% CAGR, speaks volumes about where the industry's heading. What's...

Continue Reading
Genefluence Launches Rapid UTI PCR Test at Chelsea Hospital

Updated Category News Views 76

There's a fresh breeze blowing through the dusty corridors of healthcare, shaking things up for the better. You see, Genefluence, the brainchild of Professor Chris Toumazou, isn't just throwing a bunch of tech jargon around—it's setting the stage for a much-needed shake-up in how we handle urinary tract infections (UTIs) and, believe me, it couldn’t have come sooner....

Continue Reading

Top 5 Most Recently Viewed Articles

Semler Scientific Faces Class Action Lawsuit Amid Stock Drops

Updated Category News Views 353

Semler Scientific Under Legal Scrutiny Pomerantz LLP has announced that a class action lawsuit has been initiated against Semler Scientific, Inc. (NASDAQ: SMLR). This legal action is directed towards investors who believe they have suffered losses related to their investments in Semler. If you identify with this situation, it's crucial to reach out to a legal...

Continue Reading
Investors of Ford Motor Company Urged to Act on Lead Plaintiff Deadline

Updated Category News Views 188

Crucial Legal Update for Ford Motor Company Investors When it comes to safeguarding your investments, timing is everything. If you're an investor in Ford Motor Company (NYSE: F), it's important to be aware of an upcoming lead plaintiff deadline that's critical for taking action. A pending class action lawsuit highlights serious misrepresentations and operational issues...

Continue Reading
Procter & Gamble Positioned for Long-Term Success Amid Challenges

Updated Category News Views 383

The Procter & Gamble Company Performance Overview The Procter & Gamble Company (NYSE: PG) has demonstrated remarkable resilience, surpassing forecasts for both organic sales and margins during the recent quarter. Despite the challenging economic landscape, the company's commitment to maintaining its full-year revenue and earnings per share (EPS) guidance remains...

Continue Reading
Eos Energy Welcomes Joseph Nigro to Its Board of Directors

Updated Category News Views 252

Joseph Nigro Joins Eos Energy Enterprises Board EDISON, N.J. — Eos Energy Enterprises, Inc. (NASDAQ: EOSE), a key player in energy storage solutions, recently announced the appointment of Joseph Nigro to its Board of Directors, effective immediately. Bringing a wealth of experience from the energy sector, Nigro's role is poised to be pivotal as the company continues its...

Continue Reading
Plug Power Faces Challenges Post Q3 Earnings Report

Updated Category News Views 168

Overview of Recent Performance Plug Power Inc (NASDAQ: PLUG) has been facing significant trading challenges recently as the market responds to a mixed third-quarter earnings report. The report revealed unmet revenue expectations and evolved investor sentiment, leading to a dip in share prices. Investors are vigilantly observing the company's financial trajectory and...

Continue Reading